Anti-neutrophil cytoplasmic antibody

Results 231 to 240 of about 37,560 (244)

Some of the next articles are maybe not open access.

Anti‐neutrophil cytoplasmic antibodies in vasculitic peripheral neuropathy

Neurology, 1993
Anti-neutrophil cytoplasmic antibodies (ANCA) have been reported to be specific serologic markers of systemic necrotizing vasculitis. We looked for ANCA in 166 consecutive patients referred for evaluation of peripheral neuropathy, wondering if ANCA might be helpful in diagnosing vasculitic neuropathy.
C H, Chalk, H A, Homburger, P J, Dyck
openaire +2 more sources

Anti-neutrophil cytoplasmic antibodies

Respiratory Medicine, 1993
W.U. Hassan, A.F. Henderson
openaire +1 more source

Anti-neutrophil cytoplasm antibodies can recognize vascular endothelial cell-bound anti-neutrophil cytoplasm antibody-associated autoantigens.

Experimental nephrology, 1994
Anti-neutrophil cytoplasm antibodies (ANCA) are strongly associated with the development of systemic vasculitis. Myeloperoxidase and proteinase-3 have been identified as targets for P-ANCA and C-ANCA, respectively. Both enzymes are released from neutrophil azurophil granules following neutrophil activation and both are highly cationic.
C O, Savage, G, Gaskin, C D, Pusey, J D, Pearson +3 more
openaire +1 more source

ANTI-NEUTROPHIL CYTOPLASM ANTIBODIES 1988